New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
16:24 EDTMRK, DOLE, ZIP, UNH, X, JNJ, HPQ, SKUL, CAROn The Fly: Closing Wrap
Stocks on Wall Street were significantly higher after U.S. lawmakers agreed on a deal to prevent falling off the fiscal cliff late last night. Several issues, including the debt ceiling, were pushed off by the agreement, but the stop-gap measure provided investors with enough temporary stability to send the market sharply higher at the open. The averages did not move far from their early levels and closed at the highs of the session... ECONOMIC EVENTS: In the U.S., Markit's final reading for December's purchasing managers' index came in at 54.0, which was up from 52.8 a month ago and beat expectations for a downward revision to 53.6. The ISM's December manufacturing PMI had a reading of 50.7, versus the expected 50.5, while the prices paid index came in at 55.5, versus the expected 50.8. A separate report showed construction spending fell 0.3% in November, versus an expected increase of 0.6%... COMPANY NEWS: Every member of the Dow Jones Industrial Average gained on the session, though UnitedHealth (UNH) rose only 30c, or 0.55%, to $54.54 and fellow healthcare companies Merck (MRK) and Johnson & Johnson (JNJ) were the average's other laggards. Shares of Hewlett-Packard (HPQ) lead the index, gaining 77c, or 5.4%, to $15.02... MAJOR MOVERS: Among the notable gainers was Zipcar (ZIP), which rose $3.94, or 47.82%, to $12.18 following its agreement to be acquired for $12.25 per share in cash by Avis Budget (CAR). Avis shares also gained 95c, or 4.79%, to $20.77. Also higher were shares of U.S. Steel (X), up $2.04, or 8.55%, to $25.89 after an upgrade to Outperform and a price target raise to $30 from $20 per share at Credit Suisse. Among noteworthy losers were shares of Dole Food (DOLE), which fell $1.54, or 13.43%, to $9.93 after the company said its fresh fruit business continues to experience declining earnings. Also lower was Skullcandy (SKUL), down 99c, or 12.71%, to $6.80 after Jefferies downgraded the stock two notches, to Underperform from Buy... INDICES: The Dow was up 308.41, or 2.35%, to 13,412.55; the Nasdaq was up 92.75, or 3.07%, to 3,112.26; and the S&P 500 was up 36.23, or 2.54%, to 1,462.42.
News For HPQ;UNH;MRK;JNJ;ZIP;CAR;X;DOLE;SKUL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 21, 2015
16:03 EDTUNHAetna makes offer to acquire Humana, WSJ says
Subscribe for More Information
13:14 EDTMRKMerck shares could return 25%, Barron's says
Subscribe for More Information
June 19, 2015
16:24 EDTUNHStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
10:09 EDTUNHFly Watch: Supreme Court may release key ACA decision soon
Subscribe for More Information
07:44 EDTHPQTamr receives $25.2M in financing from HP Ventures, Thomson Reuters, others
Tamr announced that it has raised $25.2M in Series B financing from Hewlett Packard Ventures (HPQ); Thomson Reuters (TRI); MassMutual Ventures, the corporate venture capital arm of Massachusetts Mutual Life Insurance Company and others. Current Tamr investors NEA and Google Ventures (GOOG) also participated in the round. Tamr will use the funds to significantly grow sales as well as product engineering for Tamr’s scalable data unification platform.
07:37 EDTUNHSupreme Court decision on ACA suit due soon, says UBS
Subscribe for More Information
June 18, 2015
15:05 EDTHPQOracle hires David Donatelli to lead Converged Infrastructure
Subscribe for More Information
11:31 EDTUNHOptions with increasing implied volatility
Subscribe for More Information
11:01 EDTCARAvis Budget, JetBlue sign preferred partnership agreement
Avis Budget Group (CAR) announced that it has signed a multi-year preferred partnership agreement with JetBlue Airways (JBLU). The new agreement significantly expands the existing marketing affiliation between the two companies, under which Avis Budget Group has served as a partner within JetBlue's TrueBlue loyalty rewards program. Under the new agreement, Avis Budget Group will promote its Avis Car Rental, Budget Car Rental and Payless Car Rental brands, products and services as well as money-saving offers directly to JetBlue customers and TrueBlue members. TrueBlue members and those with Mosaic status will have the opportunity to earn TrueBlue points when renting from Avis, Budget and Payless. The three rental brands will also be featured on JetBlue's online booking channel located at www.jetblue.com so that travelers can conveniently make car rental reservations when purchasing airline tickets.
05:57 EDTUNHStocks with implied volatility movement; UNH JD
Subscribe for More Information
June 17, 2015
19:55 EDTXU.S. Steel CEO: 'everything on the table' in trying to save company, WSJ says
U.S. Steel CEO Mario Longhi stated that "everything is on the table," including layoffs and changes to its manufacturing process, in trying to save the company, reports the Wall Street Journal. Reference Link
17:00 EDTMRKOncoSec CEO expects 'to be in a better position to attract a strategic partner'
Subscribe for More Information
11:08 EDTUNHOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTMRKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
08:03 EDTMRKMerck Keytruda granted FDA orphan designation as gastric cancer treatment
The FDA granted Merck, Sharp & Dohme, a subsidiary of Merck, orphan status for Keytruda as a treatment of gastric cancer, including gastroesophageal junction adenocarcinoma. Reference Link
07:48 EDTUNHHealth insurers seen consolidating from five to three in 'megadeals,' WSJ says
Subscribe for More Information
07:42 EDTUNHAetna price target raised to $145 from $135 at Leerink
Subscribe for More Information
07:27 EDTUNHUnitedHealth growth set to accelerate, says Wells Fargo
Subscribe for More Information
07:21 EDTJNJGeneric ADHD drugs still sold despite FDA non-equivalance finding, NYT reports
The FDA announced last November that two generic versions of Johnson & Johnson's (JNJ) Concerta ADHD drug, one made by Mallinckrodt (MNK) and the other by UCB, could no longer be considered the equivalent of the branded drug after tests and analyses suggested that their effectiveness began to wear off much more quickly, but the drugs are still being sold despite an FDA mandated deadline having passed for the companies to either prove the drugs were equivalent or remove them from the market, said The New York Times. The report noted a third generic product, sold by Actavis (AGN), was found to be equivalent to the branded Concerta. Reference Link
05:31 EDTMRKMerck initiated with a Neutral at Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use